1. Home
  2. EJH vs GLTO Comparison

EJH vs GLTO Comparison

Compare EJH & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EJH
  • GLTO
  • Stock Information
  • Founded
  • EJH 2018
  • GLTO 2011
  • Country
  • EJH China
  • GLTO Denmark
  • Employees
  • EJH N/A
  • GLTO N/A
  • Industry
  • EJH Other Consumer Services
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • EJH Consumer Discretionary
  • GLTO Health Care
  • Exchange
  • EJH Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • EJH 4.8M
  • GLTO 6.5M
  • IPO Year
  • EJH 2021
  • GLTO 2020
  • Fundamental
  • Price
  • EJH $0.56
  • GLTO $4.71
  • Analyst Decision
  • EJH
  • GLTO Buy
  • Analyst Count
  • EJH 0
  • GLTO 1
  • Target Price
  • EJH N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • EJH 1.5M
  • GLTO 17.6K
  • Earning Date
  • EJH 10-29-2024
  • GLTO 03-07-2025
  • Dividend Yield
  • EJH N/A
  • GLTO N/A
  • EPS Growth
  • EJH N/A
  • GLTO N/A
  • EPS
  • EJH N/A
  • GLTO N/A
  • Revenue
  • EJH $50,685,314.00
  • GLTO N/A
  • Revenue This Year
  • EJH N/A
  • GLTO N/A
  • Revenue Next Year
  • EJH N/A
  • GLTO N/A
  • P/E Ratio
  • EJH N/A
  • GLTO N/A
  • Revenue Growth
  • EJH N/A
  • GLTO N/A
  • 52 Week Low
  • EJH $0.53
  • GLTO $4.40
  • 52 Week High
  • EJH $36.70
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • EJH 48.44
  • GLTO 45.14
  • Support Level
  • EJH $0.67
  • GLTO $4.70
  • Resistance Level
  • EJH $1.03
  • GLTO $5.11
  • Average True Range (ATR)
  • EJH 0.12
  • GLTO 0.38
  • MACD
  • EJH 0.01
  • GLTO -0.01
  • Stochastic Oscillator
  • EJH 33.49
  • GLTO 26.23

About EJH E-Home Household Service Holdings Limited

E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving the orders online and providing the services offline. Its operations are organized into five reportable segments: installation and maintenance services, housekeeping services, senior care services, sales of pharmaceutical products and educational consulting services. The group's principal source of revenue comes from the Installation and Maintenance segment, followed by Housekeeping and Senior care services segment.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: